GV 2016, L.P. 13D and 13G filings for Arcus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 12:30 pm Sale |
2021-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
GV 2016, L.P. | 2,563,441 3.650% |
-2,486,345![]() (-49.24%) |
Filing |